Related Experiment Videos
[Posttreatment hypothyroidism in diffuse toxic goiter. A complication or evolution?]
D Navarro Despaigne1, F Ripoll Ripoll
1Instituto Superior de Ciencias Médicas, Hospital Docente Clínico Quirúrgico 12 de Octubre, Ciudad de La Habana, Cuba.
Anales De Medicina Interna (Madrid, Spain : 1984)
|November 1, 1990
Abstract:
Hypothyroidism posttreatment of diffuse toxic goiter (DTG) might depend on both treatment of inherent disease factors. 147 patients afflicted with DTG, with at least 3 years under treatment, were studied to identify these factors. Clinical evaluation was performed and TSH and T4T were measured (RIA). 49% had hypothyroidism, 17% of this percentage having been diagnosed during the study. We found these hypothyroidism protector factors: familiar background of thyroid disease, gap between doses of 131 1 greater than of 8 months and as favoring factor: surgical treatment.